Thiamine and estimated glomerular filtration rate in type 2 diabetes with chronic kidney disease stage 3: A pragmatic randomized controlled trial
Phase 4
Completed
- Conditions
- Thiamineestimated glomerular filtration rateKidney Function: estimated glomerular filtration rate change between grouptype 2 diabeteschronic kidney disease stage 3
- Registration Number
- TCTR20200215004
- Lead Sponsor
- Family Medicine Khon Kaen Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Type 2 Diabetes with chronic kidney disease stage 3
Exclusion Criteria
1.History of Thiamine allergy
2.History of cardiovascular disease
3.History of Kidney stone
4.History of kidney surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Kidney Function between group at 6 months after end of the intervention estimated glomerular filtration rate (eGFR) change between group
- Secondary Outcome Measures
Name Time Method Kidney Function within group at 6 months after end of the intervention 1.eGFR change within group ,Diabetes control between group at 6 months after end of the intervention Hb A1C change between group,Lipid level between group at 6 months after end of the intervention Cholesterol,LDL,HDL and triglyceride change between group, Urine microalbumine between group at 6 months after end of the intervention Urine microalbumine change between group,Adverse events and serious events at 6 months after end of the intervention Adverse events and serious events